1 completed, 1 unknown, 1 withdrawn. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 1, Unknown 1, Withdrawn 1 |
Follow Diabetic Nephropathy Type 2: new trials by email Literature Review of Diabetic Nephropathy Type 2 trials Research Report on Diabetic Nephropathy Type 2
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Impact of Dapagliflozin as Add-on Therapy on Glycemic Status and Quality of Life in Type 2 Diabetic Patients Dapagliflozin - Diabetic Nephropathy Type 2 | Phase 4 | Completed | Mohammed Mahmood Mohammed | 40 | 2022-05-01 | 2024-03-22 |
| Safety and Efficacy of Two Year of RAAS Alone or in Combination With Spironolactone Therapy Renin-Angiotensin (RAAS) alone, Renin-Angiotensin (RAAS) blockers in combination with Spironolactone - Renal Insufficiency, Chronic, Diabetic Nephropathy Type 2 | Phase 4 | Unknown | James A. Tumlin, MD | 72 | 2018-10-01 | 2022-10-28 |
| Rotation for Optimal Targeting of Albuminuria and Treatment Evaluation (ROTATE-2) Linagliptin, Empagliflozin, Telmisartan - Diabetic Nephropathy Type 2 | Phase 4 | Withdrawn | Steno Diabetes Center Copenhagen | 2017-11-15 | 2018-09-14 |
Renal Insufficiency, Chronic (1)
Chronic Disease (1) · Disease Attributes (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Kidney Diseases (1) · Male Urogenital Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Renal Insufficiency (1) · Urogenital Diseases (1) · Urologic Diseases (1)
Enalapril (1) · Linagliptin (1) · Lisinopril (1) · Losartan (1) · Perindopril (1) · Single Person (1) · Spironolactone (1) · Telmisartan (1) · Valsartan (1) · dapagliflozin (1) · empagliflozin (1) · glucuronyl glucosamine glycan sulfate (1)
James A. Tumlin, MD (1) · Mohammed Mahmood Mohammed (1) · Steno Diabetes Center Copenhagen (1)
Denmark (1) · Iraq (1) · United States (1)